European Hematology Association - 31st Congress, 2026 (EHA) 11 - 14 June 2026

Phase 1/2 hibiscus kids study of etavopivat in pediatric patients with sickle cell disease: safety and efficacy findings from the complete first cohort

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Sickle Cell Disease

Congress oral presentation

Etavopivat

Are you a healthcare professional?